• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性红细胞增多性红斑肢痛症:SCN9A 突变所致:自然病史、临床表型和躯体感觉特征。

Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile.

机构信息

Neusentis, Pfizer Ltd, the Portway Building, Granta Park, CB21 6GS, UK, Cambridge.

Centre for Neuroscience and Regeneration Research, Yale University Medical School, New Haven, CT 06510 And Neuroscience Research Centre (Bldg. 34), Veterans Affairs Connecticut Healthcare, West Haven, CT, 06516, USA.

出版信息

Brain. 2016 Apr;139(Pt 4):1052-65. doi: 10.1093/brain/aww007. Epub 2016 Feb 26.

DOI:10.1093/brain/aww007
PMID:26920677
Abstract

Inherited erythromelalgia, the first human pain syndrome linked to voltage-gated sodium channels, is widely regarded as a genetic model of human pain. Because inherited erythromelalgia was linked to gain-of-function changes of sodium channel Na(v)1.7 only a decade ago, the literature has mainly consisted of reports of genetic and/or clinical characterization of individual patients. This paper describes the pattern of pain, natural history, somatosensory profile, psychosocial status and olfactory testing of 13 subjects with primary inherited erythromelalgia with mutations of SCN9A, the gene encoding Na(v)1.7. Subjects were clinically profiled using questionnaires, quantitative sensory testing and olfaction testing during the in-clinic phase of the study. In addition, a detailed pain phenotype for each subject was obtained over a 3-month period at home using diaries, enabling subjects to self-report pain attacks, potential triggers, duration and severity of pain. All subjects reported pain and heat in the extremities (usually feet and/or hands), with pain attacks triggered by heat or exercise and relieved mainly by non-pharmacological manoeuvres such as cooling. A large proportion of pain attacks (355/1099; 32%) did not involve a specific trigger. There was considerable variability in the number, duration and severity of pain attacks between subjects, even those carrying the same mutation within a family, and within individuals over the 12-13 week observation period. Most subjects (11/13) had pain between attacks. For these subjects, mean pain severity between pain attacks was usually lower than that during an attack. Olfaction testing using the Sniffin'T test did not demonstrate hyperosmia. One subject had evidence of orthostatic hypotension. Overall, there was a statistically significant correlation between total Hospital Anxiety and Depression Scale scores (P= 0.005) and pain between attacks and for Hospital Anxiety and Depression Scale Depression scores and pain between attacks (P= 0.001). Hospital Anxiety and Depression Scale scores for five subjects were below the threshold for mild anxiety or depression and none of the 13 subjects were severely anxious and/or depressed. Quantitative sensory testing revealed significantly increased detection thresholds for cold and warm stimuli at affected, compared to unaffected sites. By contrast, significantly decreased cold and heat pain thresholds were found at unaffected sites. Sensory profiles varied considerably between affected and unaffected sites, suggesting the existence of small fibre neuropathy in symptomatic sites. This in-depth clinical characterization of a well-defined inherited erythromelalgia population indicates the importance of characterizing the pain phenotype in individuals before undertaking clinical trials, given the inherent variability of pain both between and within inherited erythromelalgia subjects, even those within a family who carry the same mutation.

摘要

遗传性红斑性肢痛症,首个与电压门控钠离子通道相关的人类痛觉综合征,被广泛认为是人类疼痛的遗传模型。由于遗传性红斑性肢痛症与钠离子通道 Na(v)1.7 的功能获得性改变相关仅在十年前才被发现,因此文献主要由个体患者的遗传和/或临床特征报告组成。本文描述了 13 名携带 SCN9A 基因突变的原发性遗传性红斑性肢痛症患者的疼痛模式、自然病史、体感特征、社会心理状况和嗅觉测试。在研究的门诊阶段,通过问卷调查、定量感觉测试和嗅觉测试对受试者进行临床分析。此外,通过使用日记在家中进行为期 3 个月的详细疼痛表型研究,使受试者能够自我报告疼痛发作、潜在触发因素、疼痛的持续时间和严重程度。所有受试者均报告四肢(通常是脚和/或手)有疼痛和灼热感,疼痛发作由热或运动引发,主要通过冷却等非药物手段缓解。相当一部分疼痛发作(355/1099;32%)没有特定的诱因。即使是携带相同基因突变的家族内的受试者,以及在 12-13 周的观察期内的个体,疼痛发作的数量、持续时间和严重程度也存在很大差异。大多数受试者(11/13)在发作之间有疼痛。对于这些受试者,发作之间的平均疼痛严重程度通常低于发作时的疼痛严重程度。使用 Sniffin'Test 进行嗅觉测试并未显示出嗅觉过度。一名受试者有直立性低血压的证据。总体而言,医院焦虑和抑郁量表总分(P=0.005)与发作之间的疼痛以及医院焦虑和抑郁量表抑郁评分与发作之间的疼痛之间存在统计学显著相关性(P=0.001)。5 名受试者的医院焦虑和抑郁量表评分低于轻度焦虑或抑郁的阈值,而 13 名受试者中没有一人有严重的焦虑和/或抑郁。与未受影响部位相比,受影响部位的冷、温刺激检测阈值明显升高。相比之下,未受影响部位的冷、热痛觉阈值明显降低。体感特征在受影响和未受影响的部位之间差异很大,表明在症状部位存在小纤维神经病。对明确遗传性红斑性肢痛症人群进行的这种深入的临床特征描述表明,鉴于遗传性红斑性肢痛症受试者之间甚至是携带相同突变的家族内受试者之间的疼痛都存在固有变异性,在进行临床试验之前对个体的疼痛表型进行特征描述非常重要。

相似文献

1
Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile.遗传性红细胞增多性红斑肢痛症:SCN9A 突变所致:自然病史、临床表型和躯体感觉特征。
Brain. 2016 Apr;139(Pt 4):1052-65. doi: 10.1093/brain/aww007. Epub 2016 Feb 26.
2
Mutation in Na 1.7 causes high olfactory sensitivity.突变 Na 1.7 导致嗅觉灵敏度高。
Eur J Pain. 2018 Nov;22(10):1767-1773. doi: 10.1002/ejp.1272. Epub 2018 Jul 11.
3
Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series.儿科红斑性肢痛症和 SCN9A 突变:系统评价和单中心病例系列。
J Pediatr. 2019 Mar;206:217-224.e9. doi: 10.1016/j.jpeds.2018.10.024. Epub 2018 Nov 9.
4
Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.来自遗传性红斑性肢痛症家族的Nav1.7-A1632G突变:热刺激诱发的背根神经节神经元放电增强
J Neurosci. 2016 Jul 13;36(28):7511-22. doi: 10.1523/JNEUROSCI.0462-16.2016.
5
Primary erythromelalgia: a review.原发性红斑性肢痛症:综述
Orphanet J Rare Dis. 2015 Sep 30;10:127. doi: 10.1186/s13023-015-0347-1.
6
Bilateral congenital corneal anesthesia in a patient with SCN9A mutation, confirmed primary erythromelalgia, and paroxysmal extreme pain disorder.一名患有SCN9A突变、确诊为原发性红斑性肢痛症和阵发性剧痛障碍的患者出现双侧先天性角膜麻醉。
J AAPOS. 2015 Oct;19(5):478-9. doi: 10.1016/j.jaapos.2015.05.015.
7
A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7.原发性红斑性肢痛症中的一种新型SCN9A突变(F826Y)改变了Nav1.7的兴奋性。
Curr Mol Med. 2017;17(6):450-457. doi: 10.2174/1566524017666171009105029.
8
Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.采用卡马西平和加巴喷丁治疗 SCN9A 基因突变所致原发性红斑性肢痛症(红斑痛)患者。SCN9A 基因编码电压门控钠离子通道。
Clin Exp Dermatol. 2009 Dec;34(8):e640-2. doi: 10.1111/j.1365-2230.2009.03355.x. Epub 2009 Jun 22.
9
Pain disorders and erythromelalgia caused by voltage-gated sodium channel mutations.电压门控钠离子通道突变导致的疼痛障碍和红斑性肢痛症。
Curr Neurol Neurosci Rep. 2012 Feb;12(1):76-83. doi: 10.1007/s11910-011-0233-8.
10
Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia.先天性无痛症和红斑性肢痛症中 SCN9A 突变不常见。
J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):386-91. doi: 10.1136/jnnp-2012-303719. Epub 2012 Nov 5.

引用本文的文献

1
Enhanced trafficking of an inherited erythromelalgia Na1.7 mutant channel at a physiological temperature.遗传性红斑性肢痛症Na1.7突变通道在生理温度下的转运增强。
Neurobiol Pain. 2025 Jun 18;18:100188. doi: 10.1016/j.ynpai.2025.100188. eCollection 2025 Jul-Dec.
2
Comparative Efficacy and Tolerability of Treatments for Erythromelalgia: A Systematic Review.红斑性肢痛症治疗的比较疗效和耐受性:一项系统评价
Medicina (Kaunas). 2025 May 19;61(5):920. doi: 10.3390/medicina61050920.
3
Dorsal raphe GABA-ergic neurons regulate the susceptibility to social transfer of pain in mice.
中缝背侧γ-氨基丁酸能神经元调节小鼠疼痛社会传递的易感性。
Acta Pharmacol Sin. 2025 Feb 26. doi: 10.1038/s41401-025-01494-x.
4
Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia Patients.在少数红斑性肢痛症患者中检测到SCN9A基因的遗传变异。
Acta Derm Venereol. 2025 Jan 24;105:adv42022. doi: 10.2340/actadv.v105.42022.
5
Midbrain glutamatergic circuit mechanism of resilience to socially transferred allodynia in male mice.中脑谷氨酸能回路机制对雄性小鼠社会转移性触诱发痛的适应能力。
Nat Commun. 2024 Jun 10;15(1):4947. doi: 10.1038/s41467-024-49340-8.
6
Erythromelalgia caused by the missense mutation p.Arg220Pro in an alternatively spliced exon of SCN9A (NaV1.7).因 SCN9A(NaV1.7)剪接外显子中的错义突变 p.Arg220Pro 引起的红细胞增多症。
Hum Mol Genet. 2024 Jan 7;33(2):103-109. doi: 10.1093/hmg/ddad152.
7
Paradoxical heat sensation as a manifestation of thermal hypesthesia: a study of 1090 patients with lesions of the somatosensory system.作为热感觉迟钝表现的矛盾性热感觉:1090 例躯体感觉系统病变患者的研究。
Pain. 2024 Jan 1;165(1):216-224. doi: 10.1097/j.pain.0000000000003014. Epub 2023 Aug 11.
8
Clinical Challenges in Primary Erythromelalgia: a Real-Life Experience from a Single Center and a Diagnostic-Therapeutic Flow-Chart Proposal.原发性红斑性肢痛症的临床挑战:来自单一中心的真实病例及诊断-治疗流程图建议
Dermatol Pract Concept. 2023 Jul 1;13(3):e2023191. doi: 10.5826/dpc.1303a191.
9
Not Another Presentation of Cellulitis: A Case Report of Erythromelalgia.蜂窝织炎的另一种表现:红皮病性肢痛症病例报告
J Educ Teach Emerg Med. 2022 Jan 15;7(1):V31-V34. doi: 10.21980/J8BD2K. eCollection 2022 Jan.
10
Case report: Spinal cord stimulation in the treatment of pediatric erythromelalgia.病例报告:脊髓刺激治疗小儿红斑性肢痛症
Front Neurol. 2023 May 18;14:1143241. doi: 10.3389/fneur.2023.1143241. eCollection 2023.